| MeSH term | MeSH ID | Detail |
|---|---|---|
| Keratosis | D007642 | 9 associated lipids |
| Laryngeal Neoplasms | D007822 | 7 associated lipids |
| Lip Neoplasms | D008048 | 3 associated lipids |
| Listeriosis | D008088 | 12 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Lung Diseases | D008171 | 37 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Lymphatic Metastasis | D008207 | 10 associated lipids |
| Lymphoma, Follicular | D008224 | 3 associated lipids |
| Lymphoproliferative Disorders | D008232 | 7 associated lipids |
HEMATOXYLIN
HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.
Cross Reference
Introduction
To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with HEMATOXYLIN?
HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN
PubChem Associated disorders and diseases
What pathways are associated with HEMATOXYLIN
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with HEMATOXYLIN?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with HEMATOXYLIN?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with HEMATOXYLIN?
There are no associated biomedical information in the current reference collection.
What genes are associated with HEMATOXYLIN?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with HEMATOXYLIN?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with HEMATOXYLIN
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Zhang GY et al. | Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma. | 2005 | Br. J. Cancer | pmid:15583697 |
| Hu DE et al. | Early detection of tumour immune-rejection using magnetic resonance imaging. | 2003 | Br. J. Cancer | pmid:12671716 |
| Watson PH et al. | Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma. | 2003 | Br. J. Cancer | pmid:12671706 |
| Aaltonen K et al. | Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides. | 2006 | Br. J. Cancer | pmid:16670718 |
| Unger K et al. | RET rearrangements in post-Chernobyl papillary thyroid carcinomas with a short latency analysed by interphase FISH. | 2006 | Br. J. Cancer | pmid:16641909 |
| Cham KK et al. | Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma. | 2010 | Br. J. Cancer | pmid:20531411 |
| Bocci G et al. | Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib. | 2008 | Br. J. Cancer | pmid:18443598 |
| Varani J et al. | Vascular tube formation on matrix metalloproteinase-1-damaged collagen. | 2008 | Br. J. Cancer | pmid:18443597 |
| Murayama T et al. | Relation between outcomes and localisation of p-mTOR expression in gastric cancer. | 2009 | Br. J. Cancer | pmid:19223902 |
| Smith SL et al. | S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas. | 2004 | Br. J. Cancer | pmid:15467767 |
| Miyoshi N et al. | Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis. | 2009 | Br. J. Cancer | pmid:19904274 |
| Yokota N et al. | Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells. | 2009 | Br. J. Cancer | pmid:19904262 |
| Iijima H et al. | Allelic losses on chromosome 3p are accumulated in relation to morphological changes of lung adenocarcinoma. | 2004 | Br. J. Cancer | pmid:15292942 |
| Palfi S et al. | Correlation of in vitro infiltration with glioma histological type in organotypic brain slices. | 2004 | Br. J. Cancer | pmid:15292940 |
| Hibi K et al. | Methylation pattern of CDH13 gene in digestive tract cancers. | 2004 | Br. J. Cancer | pmid:15292927 |
| Suzuoki M et al. | Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. | 2002 | Br. J. Cancer | pmid:12402154 |
| Kikuchi R et al. | Nuclear BAG-1 expression reflects malignant potential in colorectal carcinomas. | 2002 | Br. J. Cancer | pmid:12402153 |
| Connolly EM et al. | Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer. | 2002 | Br. J. Cancer | pmid:12107848 |
| Anders M et al. | Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression. | 2009 | Br. J. Cancer | pmid:19142187 |
| Dudderidge TJ et al. | Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer. | 2007 | Br. J. Cancer | pmid:17406359 |
| Fritzsche F et al. | Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status. | 2006 | Br. J. Cancer | pmid:16434994 |
| Ino K et al. | Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival. | 2006 | Br. J. Cancer | pmid:16434990 |
| Barnes N et al. | Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence. | 2006 | Br. J. Cancer | pmid:16421596 |
| Le Page C et al. | Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer. | 2006 | Br. J. Cancer | pmid:16421595 |
| D'Arcy V et al. | BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours. | 2008 | Br. J. Cancer | pmid:18195709 |
| Graf MR et al. | The neuro-steroid, 3beta androstene 17alpha diol exhibits potent cytotoxic effects on human malignant glioma and lymphoma cells through different programmed cell death pathways. | 2007 | Br. J. Cancer | pmid:17637679 |
| Kaneko K et al. | Pathological features and genetic alterations in colorectal carcinomas with characteristics of nonpolypoid growth. | 2004 | Br. J. Cancer | pmid:15213719 |
| Miyazono F et al. | Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer. | 2004 | Br. J. Cancer | pmid:15213712 |
| Mathioudaki K et al. | The PRMT1 gene expression pattern in colon cancer. | 2008 | Br. J. Cancer | pmid:19078953 |
| Salazar-Onfray F et al. | Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker. | 2002 | Br. J. Cancer | pmid:12177778 |
| Fan Y et al. | Nucleostemin mRNA is expressed in both normal and malignant renal tissues. | 2006 | Br. J. Cancer | pmid:16670719 |
| Aubele M et al. | PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas. | 2007 | Br. J. Cancer | pmid:17299391 |
| Roche-Nagle G et al. | Antimetastatic activity of a cyclooxygenase-2 inhibitor. | 2004 | Br. J. Cancer | pmid:15213717 |
| Chiyomaru T et al. | miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. | 2010 | Br. J. Cancer | pmid:20160723 |
| Barnes NL et al. | Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer. | 2007 | Br. J. Cancer | pmid:17285134 |
| Kaneko K et al. | Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus. | 2007 | Br. J. Cancer | pmid:17285122 |
| Kabuubi P et al. | No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix. | 2006 | Br. J. Cancer | pmid:16317434 |
| Foster CS et al. | Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement. | 2009 | Br. J. Cancer | pmid:19707199 |
| Rennel ES et al. | VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo. | 2009 | Br. J. Cancer | pmid:19707198 |
| Lin HJ et al. | Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer. | 2005 | Br. J. Cancer | pmid:16288304 |
| Gibcus JH et al. | Cortactin expression predicts poor survival in laryngeal carcinoma. | 2008 | Br. J. Cancer | pmid:18268491 |
| Hekmatyar SK et al. | ¹H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice. | 2010 | Br. J. Cancer | pmid:20842126 |
| Nakayama N et al. | KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer. | 2008 | Br. J. Cancer | pmid:19018267 |
| Bjørge L et al. | Ascitic complement system in ovarian cancer. | 2005 | Br. J. Cancer | pmid:15726105 |
| Yokoyama Y and Ramakrishnan S | Improved biological activity of a mutant endostatin containing a single amino-acid substitution. | 2004 | Br. J. Cancer | pmid:15083196 |
| Lau YS et al. | Malignant melanoma and bone resorption. | 2006 | Br. J. Cancer | pmid:16641914 |
| Koike C et al. | Solid stress facilitates spheroid formation: potential involvement of hyaluronan. | 2002 | Br. J. Cancer | pmid:11953828 |
| Ito Y et al. | Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid. | 2002 | Br. J. Cancer | pmid:11953823 |
| Kato T et al. | Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer. | 2007 | Br. J. Cancer | pmid:17923874 |
| Teo NB et al. | Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast. | 2002 | Br. J. Cancer | pmid:11953822 |
| Al-Yasi AR et al. | Axillary node status in breast cancer patients prior to surgery by imaging with Tc-99m humanised anti-PEM monoclonal antibody, hHMFG1. | 2002 | Br. J. Cancer | pmid:11953817 |
| Miyazaki T et al. | An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinoma. | 2004 | Br. J. Cancer | pmid:15467768 |
| Bauer J et al. | Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. | 2009 | Br. J. Cancer | pmid:19654573 |
| Teh SK et al. | Diagnostic potential of near-infrared Raman spectroscopy in the stomach: differentiating dysplasia from normal tissue. | 2008 | Br. J. Cancer | pmid:18195711 |
| Koppert LB et al. | Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression. | 2004 | Br. J. Cancer | pmid:14970870 |
| Jiao W et al. | Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. | 2002 | Br. J. Cancer | pmid:11857019 |
| Di Benedetto M et al. | Inhibition of epidermoid carcinoma A431 cell growth and angiogenesis in nude mice by early and late treatment with a novel dextran derivative. | 2003 | Br. J. Cancer | pmid:12799647 |
| Hall JS et al. | Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples. | 2011 | Br. J. Cancer | pmid:21407225 |
| Bing C et al. | Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice. | 2006 | Br. J. Cancer | pmid:17047651 |
| Graham K et al. | Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile. | 2010 | Br. J. Cancer | pmid:20197764 |
| Terry G et al. | The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions. | 2007 | Br. J. Cancer | pmid:17164758 |
| Kahlert C et al. | Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse. | 2009 | Br. J. Cancer | pmid:19603023 |
| Dudek AZ et al. | Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapy. | 2007 | Br. J. Cancer | pmid:17653078 |
| Lee YK et al. | BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers. | 2009 | Br. J. Cancer | pmid:19603021 |
| Yoshikawa D et al. | Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma. | 2008 | Br. J. Cancer | pmid:18087285 |
| Dredge K et al. | Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects. | 2002 | Br. J. Cancer | pmid:12402158 |
| Negri FV et al. | Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy. | 2008 | Br. J. Cancer | pmid:18087284 |
| Borle F et al. | Selectivity of the photosensitiser Tookad for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model. | 2003 | Br. J. Cancer | pmid:14676813 |
| Kusakari T et al. | C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro. | 2003 | Br. J. Cancer | pmid:14676809 |
| Leonard P et al. | Gene expression array profile of human osteosarcoma. | 2003 | Br. J. Cancer | pmid:14676807 |
| Lo Muzio L et al. | Survivin expression in oral squamous cell carcinoma. | 2003 | Br. J. Cancer | pmid:14676801 |
| Jamieson SM et al. | Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity. | 2003 | Br. J. Cancer | pmid:12799641 |
| Escaff S et al. | Study of matrix metalloproteinases and their inhibitors in prostate cancer. | 2010 | Br. J. Cancer | pmid:20160732 |
| Myers E et al. | A positive role for PEA3 in HER2-mediated breast tumour progression. | 2006 | Br. J. Cancer | pmid:17060941 |
| Siriwardena BS et al. | Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. | 2006 | Br. J. Cancer | pmid:17060937 |
| Alain T et al. | The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro. | 2006 | Br. J. Cancer | pmid:17047650 |
| Klevesath MB et al. | The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer. | 2005 | Br. J. Cancer | pmid:15942633 |
| Inokuchi M et al. | Quantitative evaluation of metastases in axillary lymph nodes of breast cancer. | 2003 | Br. J. Cancer | pmid:14583780 |
| Nakakubo Y et al. | Clinical significance of immune cell infiltration within gallbladder cancer. | 2003 | Br. J. Cancer | pmid:14583778 |
| Doak SH et al. | Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma. | 2003 | Br. J. Cancer | pmid:14583777 |
| Radny P et al. | Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases. | 2003 | Br. J. Cancer | pmid:14583759 |
| Reid AH et al. | Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. | 2010 | Br. J. Cancer | pmid:20104229 |
| Taylor SE et al. | Infrared spectroscopy with multivariate analysis to interrogate endometrial tissue: a novel and objective diagnostic approach. | 2011 | Br. J. Cancer | pmid:21326237 |
| Harada K et al. | Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features. | 2007 | Br. J. Cancer | pmid:17923875 |
| Dzięgiel P et al. | Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases. | 2010 | Br. J. Cancer | pmid:20648017 |
| Bussolati G et al. | A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer. | 2005 | Br. J. Cancer | pmid:15812476 |
| Fang DD et al. | Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. | 2010 | Br. J. Cancer | pmid:20332776 |
| Bugat R et al. | Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002). | 2003 | Br. J. Cancer | pmid:12915904 |
| Tasaki M et al. | ALKBH3, a human AlkB homologue, contributes to cell survival in human non-small-cell lung cancer. | 2011 | Br. J. Cancer | pmid:21285982 |
| Oladipo O et al. | The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue. | 2011 | Br. J. Cancer | pmid:21285972 |
| Akagi T et al. | Induction of sodium iodide symporter gene and molecular characterisation of HNF3 beta/FoxA2, TTF-1 and C/EBP beta in thyroid carcinoma cells. | 2008 | Br. J. Cancer | pmid:18682709 |
| Gray-Schopfer VC et al. | Cellular senescence in naevi and immortalisation in melanoma: a role for p16? | 2006 | Br. J. Cancer | pmid:16880792 |
| Kita Y et al. | Expression of osteopontin in oesophageal squamous cell carcinoma. | 2006 | Br. J. Cancer | pmid:16880782 |
| de Graeff P et al. | Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies. | 2006 | Br. J. Cancer | pmid:16880779 |
| Epping MT et al. | PRAME expression and clinical outcome of breast cancer. | 2008 | Br. J. Cancer | pmid:18648365 |
| Akil N et al. | High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study. | 2008 | Br. J. Cancer | pmid:18648363 |
| Kamura S et al. | Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway. | 2010 | Br. J. Cancer | pmid:20606682 |
| Kato T et al. | The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer. | 2003 | Br. J. Cancer | pmid:12799634 |
| Kettunen E et al. | DNA copy number loss and allelic imbalance at 2p16 in lung cancer associated with asbestos exposure. | 2009 | Br. J. Cancer | pmid:19337251 |
| Tischkowitz M et al. | Muir Torre syndrome and MSH2 mutations: the importance of dermatological awareness. | 2006 | Br. J. Cancer | pmid:16786041 |